These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 15162797

  • 1. von Hippel-Lindau tumor suppressor: not only HIF's executioner.
    Czyzyk-Krzeska MF, Meller J.
    Trends Mol Med; 2004 Apr; 10(4):146-9. PubMed ID: 15162797
    [Abstract] [Full Text] [Related]

  • 2. von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF.
    Hoffman MA, Ohh M, Yang H, Klco JM, Ivan M, Kaelin WG.
    Hum Mol Genet; 2001 May 01; 10(10):1019-27. PubMed ID: 11331612
    [Abstract] [Full Text] [Related]

  • 3. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
    Krieg M, Haas R, Brauch H, Acker T, Flamme I, Plate KH.
    Oncogene; 2000 Nov 16; 19(48):5435-43. PubMed ID: 11114720
    [Abstract] [Full Text] [Related]

  • 4. The von Hippel-Lindau tumor suppressor gene.
    Kondo K, Kaelin WG.
    Exp Cell Res; 2001 Mar 10; 264(1):117-25. PubMed ID: 11237528
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Von Hippel-Lindau gene deletion and expression of hypoxia-inducible factor and ubiquitin in optic nerve hemangioma.
    Chan CC, Lee YS, Zhuang Z, Hackett J, Chew EY.
    Trans Am Ophthalmol Soc; 2004 Mar 10; 102():75-9; discussion 79-81. PubMed ID: 15747747
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
    Zatyka M, da Silva NF, Clifford SC, Morris MR, Wiesener MS, Eckardt KU, Houlston RS, Richards FM, Latif F, Maher ER.
    Cancer Res; 2002 Jul 01; 62(13):3803-11. PubMed ID: 12097293
    [Abstract] [Full Text] [Related]

  • 9. Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein.
    Tanimoto K, Makino Y, Pereira T, Poellinger L.
    EMBO J; 2000 Aug 15; 19(16):4298-309. PubMed ID: 10944113
    [Abstract] [Full Text] [Related]

  • 10. Molecular targets from VHL studies into the oxygen-sensing pathway.
    Maynard MA, Ohh M.
    Curr Cancer Drug Targets; 2005 Aug 15; 5(5):345-56. PubMed ID: 16101382
    [Abstract] [Full Text] [Related]

  • 11. Expression of HIF-1 and ubiquitin in conventional renal cell carcinoma: relationship to mutations of the von Hippel-Lindau tumor suppressor gene.
    Hughson MD, He Z, Liu S, Coleman J, Shingleton WB.
    Cancer Genet Cytogenet; 2003 Jun 15; 143(2):145-53. PubMed ID: 12781449
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Role of exon 2-encoded beta -domain of the von Hippel-Lindau tumor suppressor protein.
    Bonicalzi ME, Groulx I, de Paulsen N, Lee S.
    J Biol Chem; 2001 Jan 12; 276(2):1407-16. PubMed ID: 11024059
    [Abstract] [Full Text] [Related]

  • 18. The von Hippel-Lindau tumour suppressor: a multi-faceted inhibitor of tumourigenesis.
    Barry RE, Krek W.
    Trends Mol Med; 2004 Sep 12; 10(9):466-72. PubMed ID: 15350900
    [No Abstract] [Full Text] [Related]

  • 19. Inactivation of the arylhydrocarbon receptor nuclear translocator (Arnt) suppresses von Hippel-Lindau disease-associated vascular tumors in mice.
    Rankin EB, Higgins DF, Walisser JA, Johnson RS, Bradfield CA, Haase VH.
    Mol Cell Biol; 2005 Apr 12; 25(8):3163-72. PubMed ID: 15798202
    [Abstract] [Full Text] [Related]

  • 20. Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein.
    Cockman ME, Masson N, Mole DR, Jaakkola P, Chang GW, Clifford SC, Maher ER, Pugh CW, Ratcliffe PJ, Maxwell PH.
    J Biol Chem; 2000 Aug 18; 275(33):25733-41. PubMed ID: 10823831
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.